Episode 063: Breast Cancer Series, Pt. 8-HER2+, Early Stage Breast Cancer

The Fellow on Call: The Heme/Onc Podcast

Content provided by Ronak Mistry and Rouleaux University Medical Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ronak Mistry and Rouleaux University Medical Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

1y ago

MP3•Episode home

We continue on our journey through early stage breast cancer, this time turning our attention to HER2+ disease. There is a lot of data in this episode, as you will both hear and see. To make this easier, we highlight key takeaways to make understanding this even easier.

Content:

- What is HER2?

- Discovery of trastuzumab

- Data for use of trastuzumab in adjuvant and neoadjuvant setting

- Data for use of pertuzumab in adjuvant and neoadjuvant setting

- Data and use of trastuzumab emtansine (TDM-1) in the adjuvant setting

- Management of HER2+ stage I breast cancer

- Highlights of key trials that shape the paradigm of management

- Our approach to management

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

121 episodes

#Ronak Mistry #Rouleaux University Medical Center #Science #Fitness #Biology #Podcasting Education #Medicine #Lung Cancer